Killed whole bacterial cells, a mucosal delivery system for the induction of immunity in the respiratory tract and middle ear: an overview

被引:24
作者
Kyd, JM [1 ]
Cripps, AW [1 ]
机构
[1] Univ Canberra, Fac Sci Appl, Gadi Res Ctr, Canberra, ACT 2601, Australia
关键词
mucosal; immunization; bacteria;
D O I
10.1016/S0264-410X(98)00441-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infectious diseases remain a leading cause of morbidity and mortality worldwide with mucosal membranes being the most frequent portals of entry of pathogenic micro-organisms. This has prompted studies aimed at the development of vaccination protocols that would lead to an increased protection of mucosae through an understanding of the common mucosal immune system as an immune communication network between mucosal sites. Recent studies have suggested that preferential subnetworks exist within the system and these studies have exploited the gut-associated lymphoid tissue (GALT)-lung sub-network in the development of oral vaccine strategies for infections of the respiratory tract and middle ear. Mucosal immunization with whole formalin killed Pseudomonas aeruginosa (Pa), Branhamella catarrhalis, nontypable Haemophilus influenzae (NTHi) or Streptococcus pneumoniae (Spn) results in enhanced homologous bacterial clearance from the lung of immune animals challenged with live bacteria. These studies have been extended to the middle ear where similar results have been observed for NTHi and Spn. Mechanisms responsible for inducing enhanced bacterial clearance from the airways include opsonising antibody, antigen specific CD4+ T helper cells, cytokine responses and recruitment of activated polymophonuclear neutrophils. The mechanisms induced by immunization which stimulates the immune system to rapidly mobilise both innate and specific immune responses during infection are the subject of ongoing research. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1775 / 1781
页数:7
相关论文
共 49 条
  • [41] CYTOKINES AS VACCINE ADJUVANTS - INTERLEUKIN-1 AND ITS SYNTHETIC PEPTIDE 163-171
    TAGLIABUE, A
    BORASCHI, D
    [J]. VACCINE, 1993, 11 (05) : 594 - 595
  • [42] MECHANISMS OF DISEASE - PATHOGENESIS OF PNEUMOCOCCAL INFECTION
    TUOMANEN, EI
    AUSTRIAN, R
    MASURE, HR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (19) : 1280 - 1284
  • [43] THE PATHOGENICITY OF HEMOPHILUS-INFLUENZAE
    TURK, DC
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1984, 18 (01) : 1 - 16
  • [44] ORAL IMMUNIZATION WITH POLYVALENT BACTERIAL LYSATE AND INFECTION WITH STREPTOCOCCUS-PNEUMONIAE - INFLUENCE ON INTERFERON-GAMMA AND PMN ELASTASE CONCENTRATIONS IN MURINE BRONCHOALVEOLAR LAVAGE FLUID
    VANDAAL, GJ
    VANTVEEN, A
    SO, KL
    MOUTON, JW
    SMIT, F
    VANHAL, PTW
    BERGMANN, KC
    LACHMANN, B
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1992, 97 (02) : 173 - 177
  • [45] RANDOMIZED COMPARATIVE-STUDY OF CEFIXIME VERSUS CEPHALEXIN IN ACUTE BACTERIAL EXACERBATIONS OF CHRONIC-BRONCHITIS
    VERGHESE, A
    ROBERSON, D
    KALBFLEISCH, JH
    SARUBBI, F
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) : 1041 - 1044
  • [46] AN ANIMAL-MODEL DEMONSTRATION OF ENHANCED CLEARANCE OF NONTYPABLE HEMOPHILUS-INFLUENZAE FROM THE RESPIRATORY-TRACT AFTER ANTIGEN STIMULATION OF GUT-ASSOCIATED LYMPHOID-TISSUE
    WALLACE, FJ
    CLANCY, RL
    CRIPPS, AW
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (02): : 311 - 316
  • [47] Lactic acid bacteria as vaccine delivery vehicles
    Wells, JM
    Robinson, K
    Chamberlain, LM
    Schofield, KM
    LePage, RWF
    [J]. ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY, 1996, 70 (2-4): : 317 - 330
  • [48] LACTOCOCCUS-LACTIS - HIGH-LEVEL EXPRESSION OF TETANUS TOXIN FRAGMENT-C AND PROTECTION AGAINST LETHAL CHALLENGE
    WELLS, JM
    WILSON, PW
    NORTON, PM
    GASSON, MJ
    LEPAGE, RWF
    [J]. MOLECULAR MICROBIOLOGY, 1993, 8 (06) : 1155 - 1162
  • [49] Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant
    Wu, HY
    Russell, MW
    [J]. VACCINE, 1998, 16 (2-3) : 286 - 292